Business Context and Reporting Period
This Form 8-K was filed by Henry Schein, Inc. on January 23, 2019, under Item 7.01 (Regulation FD Disclosure). The filing addresses a significant change in the company's veterinary distribution business involving Mars, Incorporated.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue totals, profit figures, cash flow data, or debt levels for the reporting period. The only specific financial metric disclosed is the estimated annualized revenue impact of the event described below.
- Estimated Revenue Impact: Approximately $100 million in annualized revenue from VCA, Inc. and Pet Partners.
- Margin Profile: The affected revenue is characterized by management as "low margin."
Material Changes
Mars, Incorporated has informed Henry Schein that it will consolidate most of its veterinary distribution purchases with a U.S.-based competitor of Henry Schein. This transition is scheduled to occur through the first quarter of 2019. Consequently, Henry Schein Animal Health will cease to be the primary supplier to VCA, Inc. (acquired by Mars in 2017) and Pet Partners. Management notes that while the primary supplier relationship will end, a potential future relationship may exist following the pending spin-off of the animal health business.
Outlook, Management Commentary, and Risks
Management Commentary: Henry Schein states that the loss of the VCA and Pet Partners business is not material to the earnings of Henry Schein Animal Health or Henry Schein, Inc. due to the low-margin nature of the sales.
Forward-Looking Statements and Risks: The filing includes a standard cautionary note regarding forward-looking statements. Key risks identified include:
- Highly competitive and consolidating market conditions.
- Dependence on third-party manufacturers and suppliers.
- Fluctuations in quarterly earnings and global macro-economic conditions.
- Currency fluctuations and political/economic uncertainty.
- Risks associated with the spin-off and merger of the animal health business with Direct Vet Marketing, Inc. (Vets First Choice).
- Cybersecurity threats and data privacy breaches.
Investor Verification Checklist
- Verify the exact timing of the transition period with the competitor during Q1 2019.
- Confirm the status of the pending spin-off and merger with Direct Vet Marketing, Inc. (Vets First Choice).
- Assess whether the $100 million annualized revenue figure aligns with recent quarterly reports for the animal health segment.
- Monitor future filings for updates on the "potential relationship" with VCA and Pet Partners post-spin-off.